Ireland — Non-Current Assets
Geographic · Non-Current AssetsEli Lilly Ireland — Non-Current Assets increased by 34.8% to $4.32B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 34.8%, from $3.21B to $4.32B.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2018
Last reportedQ4 2025
How to read this metric
An increase suggests significant capital investment or expansion of infrastructure within the region, while a decrease may indicate asset depreciation, divestiture, or a shift in the company's regional operational strategy.
Detailed definition
This metric represents the total value of long-term assets held by the company within the specified geographic segment t...
Peer comparison
Comparable to regional non-current asset disclosures in other multinational pharmaceutical companies, reflecting the geographic distribution of manufacturing and research footprint.
Metric ID:
lly_segment_ie_noncurrent_assetsHistorical Data
5 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $1.70B | $1.90B | $2.72B | $3.21B | $4.32B |
| QoQ Change | — | +11.5% | +43.4% | +17.7% | +34.8% |
| YoY Change | — | +11.5% | +43.4% | +17.7% | +34.8% |
Range$1.70B – $4.32B
CAGR+153.8%
Avg YoY Growth+26.9%
Median YoY Growth+26.3%
Current Streak4+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Eli Lilly's ireland — non-current assets?
- Eli Lilly (LLY) reported ireland — non-current assets of $4.32B in Q4 2025.
- How has Eli Lilly's ireland — non-current assets changed year-over-year?
- Eli Lilly's ireland — non-current assets increased by 34.8% year-over-year, from $3.21B to $4.32B.
- What does ireland — non-current assets mean?
- The total value of long-term assets, such as facilities and equipment, located within the specified geographic region.